HALAVEN (eribulin)

OFFICE ADMINISTRATION

Indications for Prior Authorization:

  • Refractory metastatic breast cancer

All of the following must be met as a condition(s) for coverage:

  • Single drug therapy for the treatment of metastatic breast cancer
  • Previous therapy with two National Comprehensive Cancer Network (NCCN) recommend chemotherapeutic regimens for the treatment of metastatic disease
  • Patient has had therapy or has a contraindication to therapy with and anthracycline and a taxane

The following indications do not meet the criteria for use established by the Western Health Advantage Pharmacy and Therapeutics Committee:

  • Any other diagnosis not listed in the approved indications

Dosing:

  • The recommended dose is up to 1.4 mg/m2 IV on days one and eight of a 21 day cycle

Approval:

One year


 

Last review date: December 2, 2013

Rite Aid Pharmacy Patients: All Rite Aid pharmacies nationwide are closing! Please be on the lookout for information from Rite Aid pharmacies about their bankruptcy and store closures. Call your Rite Aid pharmacy for questions about your prescriptions and new pharmacy options. WHA is here to help as well. Contact Us via Phone